$CTVA earnings report

Corteva's third quarter 2026 shows a sharp contrast between the company's core regions and Latin America. Net sales fell 9% to $1,591 million and organic sales fell 9%. Within that, North America organic sales rose 7% with volume up 19%, and EMEA organic sales rose 14% with price flat. Latin America organic sales fell 31% as volume dropped 24% and price fell 7%. The company attributes the Latin America decline to elevated channel inventory, delayed purchasing, farmer liquidity constraints and high interest rates. Asia Pacific organic sales grew 5%, with volume up 7% and price down 2%.

Profitability weakened more than sales. Pro forma GAAP income from continuing operations was $(54) million, against $60 million a year earlier, and pro forma GAAP EPS was $(0.08). Adjusted Pro Forma Operating EBITDA was $222 million, down 17% from $268 million, and the filing states that Adjusted Pro Forma Operating EBITDA margin eroded 140 basis points in the quarter. Adjusted Pro Forma Operating EPS was $0.06, down 57%. The company does not print a third-quarter margin figure for these measures in the documents provided.

On a nine-month basis, the picture is steadier. Net sales were $5,357 million, down 1%, and organic sales were down 4%, with volume flat and price down 4%. Adjusted Pro Forma Operating EBITDA was $943 million, essentially flat against $937 million, and the margin expanded 30 basis points to 17.6%. Adjusted Pro Forma Operating EPS was $0.76, up 49% as printed. Year-to-date pro forma GAAP income from continuing operations was $112 million, down 68%, and GAAP EPS from continuing operations was $0.16, also down 68%. The year-to-date regional table shows EMEA net sales up 7% and Asia Pacific up 6%, while Latin America was down 12%.

For the full year, the company updated its outlook, citing weaker market conditions than previously anticipated in Brazil. Adjusted Pro Forma Operating EBITDA is now expected at $1.1 billion to $1.125 billion, and Adjusted Pro Forma Operating EPS at $0.76 to $0.80 per share. The release does not print the prior guidance ranges, so this read cannot confirm the size of the change. The company also expects net pre-tax restructuring charges of approximately $130 million to $140 million in 2026 for optimizing its Crop Protection manufacturing and external partner network, with the work expected to be substantially complete in 2028.

Capital allocation is limited to one disclosure: the board authorized the first common dividend since the spin, with no amount, record date or payment date printed. The release contains no cash, debt, cash flow or balance sheet totals, so the read on liquidity and leverage is not possible from this document. The figures that deserve attention are the third-quarter Latin America decline, the swing to a GAAP loss, the 17% fall in quarterly Adjusted Pro Forma Operating EBITDA, and whether the reduced full-year range can absorb the Brazil weakness.

Corteva reported Q2 2026 GAAP net sales of $6,379 million, compared with $6,456 million in the prior-year quarter. The filing's price-volume-currency analysis showed a $ (77) (1) % GAAP sales change and a $ (134) (2) % organic sales change. Seed sales were $4,532 million, compared with $4,537 million, while Crop Protection sales were $1,847 million, compared with $1,919 million.

Seed was broadly stable at the sales level, but its mix shifted materially by product. Corn sales were $2,868 million versus $2,961 million, while soybean sales were $1,318 million versus $1,257 million and other oilseeds sales were $228 million versus $186 million. The Seed analysis showed 3 % price & portfolio / product mix and (3) % volume. Seed Operating EBITDA rose to $1,966 million from $1,863 million.

Crop Protection was the principal reported sales drag. Its Q2 analysis identified (4) % price & portfolio / product mix and (2) % volume, partly offset by 2 % currency. Nonetheless, Crop Protection Operating EBITDA was $342 million, compared with $334 million. At the consolidated level, Operating EBITDA was $2,261 million versus $2,164 million, while GAAP income from continuing operations after income taxes was $1,217 million versus $1,382 million. The GAAP comparison includes other income (expense) - net of $(115) million versus $103 million and separation costs of $79 million.

Capital allocation included $(500) million of common-stock repurchases and $(241) million of dividends paid during the Six Months Ended June 30, 2026. Operating cash flow for that six-month period was $(3,357) million, compared with $(1,162) million, and pension and OPEB contributions were $(1,140) million. Cash and cash equivalents were $2,365 million at June 30, 2026, while short-term borrowings were $3,193 million and long-term debt was $1,682 million.

No forward outlook or management commentary was included in the provided filing text. The reported period therefore leaves attention on whether Seed price and product mix can continue to offset volume pressure, whether Crop Protection can improve its reported price and volume trends, and the progression of seasonal cash flow after the first-half cash use.